Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00376909 · ClinicalTrials.gov registry record · Phase 2
A Telephone-Based Prevention Care Manager in Increasing Screening Rates for Breast Cancer, Cervical Cancer, and Colorectal Cancer in Minority and Low-Income Women
A Phase 2 study of Breast Cancer and Colorectal Cancer, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 2,729
- Enrollment target
- 2
- Study locations
NCT00376909 is a Phase 2 study of Breast Cancer and Colorectal Cancer that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 2,729 participants, roughly in line with the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target. The trial reports 2 study locations across 2 states.
The verdict
NCT00376909, a Phase 2 study of Breast Cancer and Colorectal Cancer, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 2,729 participants
- Enrollment target
- 2
- Study locations
Study Summary
RATIONALE: Studying the barriers that prevent minority and low-income women from undergoing cancer screening, and offering encouragement to them over the telephone, may help improve cancer screening rates. PURPOSE: This randomized phase II trial is studying how well a telephone-based Prevention Care Manager increases screening rates for breast cancer, cervical cancer, and colorectal cancer in minority and low-income women.
Conditions Studied
Interventions
- OTHER educational intervention
- OTHER study of socioeconomic and demographic variables
Study Locations (2)
New Hampshire
- Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center - Lebanon
New York
- Clinical Directors Network, Incorporated - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,729 participants |
| Start Date | 2001-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00376909
The ClinicalTrials.gov registry entry for NCT00376909 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 2,729 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which educational intervention is the first listed.
NCT00376909 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New Hampshire, New York.
Frequently Asked Questions
What is clinical trial NCT00376909 about?
NCT00376909 is a clinical study titled "A Telephone-Based Prevention Care Manager in Increasing Screening Rates for Breast Cancer, Cervical Cancer, and Colorectal Cancer in Minority and Low-Income Women". RATIONALE: Studying the barriers that prevent minority and low-income women from undergoing cancer screening, and offering encouragement to them over the telephone, may help improve cancer screening rates. PURPOSE: This randomized phase II trial is studying how well a telephone-based Prevention Car...
What is the current status of trial NCT00376909?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 2,729 participants. The study started on 2001-11.
What conditions does trial NCT00376909 study?
This clinical trial studies the following conditions: Breast Cancer, Colorectal Cancer, Cervical Cancer.
What interventions are being tested in trial NCT00376909?
The interventions under investigation include: educational intervention (OTHER), study of socioeconomic and demographic variables (OTHER).
Who is sponsoring clinical trial NCT00376909?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00376909 being conducted?
This trial has 2 study locations across New Hampshire, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC
RECRUITING · Phase 2
-
The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer
RECRUITING · Phase 2
-
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
RECRUITING · Phase 2
-
Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial
RECRUITING · Phase 2
-
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
RECRUITING · Phase 2
-
Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.